Register information Protection certificate

DE file number : 12 2013 000 058.9 (Status: pending/in force, Query started: April 29, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTProtection certificate
StatusSTPending/in force
21DE file number DAKZ12 2013 000 058.9
UseVZMedicinal products
95Product nameTIEZPegloticase sowie jegliche therapeutisch äquivalente vom Grundpatent geschützte Form davon
54Title of basic patentTIGZAGGREGAT-FREIE HARNSÄUREOXIDASE ZUR HERSTELLUNG VON NICHT-IMMUNOGENEN POLYMER-KONJUGATEN
51IPC main classICM
(ICMV)		 C12N 15/53 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 C12N 9/06 (2006.01), C12N 9/96 (2006.01), A61K 47/48 (2006.01), A61K 38/44 (2006.01)
94Start of term of protectionLBFeb 8, 2021
94End of term of protectionLEFeb 7, 2026
22DE application dateDATJul 5, 2013
Date of publication of application for a certificateOTSep 5, 2013
Date of publication of grant of certificatePETFeb 6, 2020
71/73Applicant/ownerINHDuke University Office of Licensing and Ventures, 2812 Erwin Road, Suite 306, Durham, N.C., US; Mountain View Pharmaceuticals, Inc., 3475-S Edison Way, Menlo Park, Calif., US
74RepresentativeVTRSSM Sandmair Patentanwälte Rechtsanwalt Partnerschaft mbB, 81829 München, DE
Address for service SSM Sandmair Patentanwälte Rechtsanwalt Partnerschaft mbB, 81806 München, DE
Patent division in charge 44
68DE file number of basic patentGAKZ601 41 742.9
68EP file number of basic patentGEAKZ01 92 3265.1
43Date of first publicationEVTSep 5, 2013
92
92
92
Domestic authorisationGIS
GIN
GIT
Europäische Kommission
EU/1/12/810
2013-01-08
93
93
93
93
EU authorisationGES
GEC
GEN
GET
Europäische Kommission
EU
EU/1/12/810
2013-01-08
Date of the first transfer into DPMAregisterEREGTSep 5, 2013
Date of the (most recent) update in DPMAregisterREGTJan 29, 2025
(Show all update days)(Hide all update days)
  • Jan 29, 2025
    • Due date: deleted
  • Aug 5, 2024
    • St.36: changed (technical change)
  • Feb 3, 2024; Jan 27, 2023; Jan 22, 2022; Jan 29, 2021; Feb 6, 2020; Dec 28, 2019; Oct 23, 2019; Jul 16, 2019; Dec 12, 2018; Aug 31, 2016; Aug 25, 2015; Jul 11, 2015; May 22, 2015; Jul 5, 2014; May 3, 2014; Mar 1, 2014; Oct 3, 2013; Sep 25, 2013
    • Historical data not available for this/these date(s)
  • Sep 5, 2013
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Supplementary protection certificate procedure Application for supplementary protection certificate effectively filed Jul 15, 2013 Sep 5, 2013 Details anzeigen
2 New applicant/owner details New applicant/owner details Jul 15, 2013  Details anzeigen
3 Supplementary protection certificate procedure Decision to grant supplementary protection certificate by Patent Division Oct 22, 2019  Details anzeigen
4 Supplementary protection certificate procedure Supplementary protection certificate granted Nov 29, 2019 Feb 6, 2020 Details anzeigen
View procedures Supplementary protection certificate procedure (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTApplication for supplementary protection certificate effectively filed
Date of legal/procedural statusVSTTJul 15, 2013
Issue numberHN36
YearPJ2013
Publication dateVTSep 5, 2013
Type of publicationPARTBibliographic data
PartHTPart 7
68DE file number of basic patentGAKZ601 41 742.9
68EP file number of basic patentGEAKZ01 92 3265.1
View procedures New applicant/owner details (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJul 15, 2013
71/73Applicant/ownerINHDuke University Office of Licensing and Ventures, Durham, N.C., US; Mountain View Pharmaceuticals, Inc., Menlo Park, Calif., US
71/73Previous applicant/ownerINHFMountain View Pharmaceuticals, Inc., Menlo Park, Calif., US, Duke University, Durham, N.C., US
View procedures Supplementary protection certificate procedure (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTDecision to grant supplementary protection certificate by Patent Division
Date of legal/procedural statusVSTTOct 22, 2019
View procedures Supplementary protection certificate procedure (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTSupplementary protection certificate granted
Date of legal/procedural statusVSTTNov 29, 2019
Issue numberHN6
YearPJ2020
Publication dateVTFeb 6, 2020
Type of publicationPARTBibliographic data
PartHTPart 7